Because an increase in PI uptake can be viewed as a reliable indicator of cell injury severity, our results suggest that pharmacological blockade of FASN activity causes significantly increased amounts of cellular damage in CCN1-overexpressing when compared with CCN1-negative breast cancer cells. The gene discussed is FASN; the disease is breast cancer.